No abstract available
Publication types
-
Clinical Trial, Phase II
-
Comparative Study
-
Letter
-
Randomized Controlled Trial
-
Validation Study
MeSH terms
-
Adult
-
Aged
-
Aged, 80 and over
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal, Murine-Derived
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cyclophosphamide / administration & dosage
-
Disease-Free Survival
-
Female
-
Humans
-
Kaplan-Meier Estimate
-
Lymphoma, Mantle-Cell / drug therapy
-
Lymphoma, Mantle-Cell / mortality*
-
Male
-
Middle Aged
-
Prognosis
-
Rituximab
-
Severity of Illness Index*
-
Survival
-
Treatment Outcome
-
Vidarabine / administration & dosage
-
Vidarabine / analogs & derivatives
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
Rituximab
-
Cyclophosphamide
-
Vidarabine
-
fludarabine